发明申请
- 专利标题: Triazolone derivatives
- 专利标题(中): 三唑酮衍生物
-
申请号: US11723893申请日: 2007-03-22
-
公开(公告)号: US20080015199A1公开(公告)日: 2008-01-17
- 发明人: Richard Clark , Fumiyoshi Matsuura , Kazunobu Kira , Shinsuke Hirota , Hiroshi Azuma , Tadashi Nagakura , Tatsuo Horizoe , Kimiyo Tabata , Kazutomi Kusano , Takao Omae , Atsushi Inoue
- 申请人: Richard Clark , Fumiyoshi Matsuura , Kazunobu Kira , Shinsuke Hirota , Hiroshi Azuma , Tadashi Nagakura , Tatsuo Horizoe , Kimiyo Tabata , Kazutomi Kusano , Takao Omae , Atsushi Inoue
- 申请人地址: JP Tokyo
- 专利权人: Eisai R&D Management Co., Ltd.
- 当前专利权人: Eisai R&D Management Co., Ltd.
- 当前专利权人地址: JP Tokyo
- 优先权: JPP2006-083486 20060324; JPP2006-162594 20060612; JPP2006-218819 20060810
- 主分类号: A61K31/4196
- IPC分类号: A61K31/4196 ; A61K31/427 ; A61K31/4439 ; A61K31/497 ; A61K31/501 ; A61K31/506 ; A61P7/02 ; A61P9/00 ; C07D249/08 ; C07D401/04 ; C07D403/04 ; C07D409/04 ; C07D417/04
摘要:
A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability. [wherein R1a, R1b, R1c and R1d each independently represent hydrogen, etc.; R2 represents optionally substituted phenyl, etc.; R3 represents optionally substituted C6-10 aryl, etc.; and Z1 and Z2 each independently represent hydrogen]
公开/授权文献
- US07816522B2 Triazolone derivatives 公开/授权日:2010-10-19
信息查询